Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-05-29 @ 4:10 PM
Study NCT ID:
NCT01578967
Status:
COMPLETED
Last Update Posted:
2021-12-07
First Post:
2012-04-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization: